SmartPill Advanced technology in the field of gastrointestinal healthcare
Nearly 6 million Americans suffering symptoms of dyspepsia, an estimated 50% may have gastroparesis or delayed emptying of the stomach. Particularly prevalent among diabetics, gastroparesis is often overlooked, and the time to diagnose is often protracted - more than two years on average.

When a patient presents with dyspeptic symptoms, arriving at a definitive diagnosis is easier said than done. Diagnostic aids for gastrointestinal disorders are few, treatment choices are limited and symptoms are often treated empirically.

The SmartPill pH.p Capsule is a single-use, ingestible capsule that measures pressure, pH and temperature from within the entire GI tract and wirelessly transmits that information to a Data Receiver worn by the patient. Once the SmartPill capsule is passed, the patient returns the Data Receiver to the physician’s office where the information is quickly downloaded to a laptop computer. SmartPill’s MotiliGI™ software then generates the test results: gastric emptying time, combined small and large bowel transit time, total transit time, antral and duodenal pressures and motility indices.

For more information:

http://www.smartpillcorp.com/site/smartpill/assets/pdf/SmartPill_GI_Monitoring_System_Brochure.pdf


About The SmartPill Corporation

The SmartPill Corporation is a developer of ingestible, capsule-based medical devices, peripheral software and electronic components that aid in the diagnosis, definition and therapeutic intervention of gastrointestinal disorders and diseases.